期刊文献+

探讨多聚胞嘧啶结合蛋白E2诱骗RNA对32D-BCR/ABL细胞增殖的影响 被引量:5

The effect of hnRNP E2 decoy RNA on proliferation of 32D-BCR/ABL cells
下载PDF
导出
摘要 目的:在慢性粒细胞白血病(chronic myeloid leukemia,CML)由慢性期向急性期的过渡阶段伴随有多聚胞嘧啶结合蛋白E2[poly(rC)-binding protein E2,hnRNP E2]的异常表达。本研究初步探讨hnRNP E2诱骗RNA(decoy RNA)对32D-BCR/ABL细胞增殖的影响及其可能的分子机制。方法:用电转染方法将hnRNP E2诱骗RNA野生序列和突变序列的表达载体(pGD和pGM)转入32D-BCR/ABL细胞,用G418筛选出稳定表达诱骗RNA的细胞。锥虫蓝染色法和克隆形成实验检测细胞的增殖能力。FCM分析细胞周期,RT-PCR和Western印迹法检测下游CCAAT增强子结合蛋白α(CCAAT/enhancer-bindingproteinα,C/EBPα)和c-Myc的表达。结果:筛选出稳定表达野生型和突变型诱骗RNA的32DP210-pGD细胞和32DP210-pGM细胞。野生型32DP210-pGD细胞与未转染32D-BCR/ABL细胞相比,其细胞增殖抑制率为(69.48±5.21)%,克隆形成能力明显减弱,细胞周期由G0/G1期向S期进展受阻;C/EBPαmRNA水平无改变,但在蛋白水平上42 ku-C/EBPα的表达增加(43.83±4.91)%;c-Myc mRNA水平下降(35.67±6.64)%,蛋白水平降低(30.91±3.84)%。突变型32DP210-pGM细胞与未转染32D-BCR/ABL的细胞相比,其上述各指标无明显差异。结论:hnRNP E2诱骗RNA能够抑制32D-BCR/ABL细胞的增殖,其机制可能是诱骗RNA阻断hnRNP E2和C/EBPαmRNA的结合,引起42 ku-C/EBPα表达增加,进而引起其下游靶基因c-Myc下调。 Objective: Exprerssion of poly (rC) -binding protein E2 ( hnRNP E2 ) was abnormal from chronic phase to blast crisis of chronic myeloid leukemia (CML). The present study was to investigate the effect of hnRNP E2 decoy RNA on the proliferation of 32D-BCR/ABL cells and the possible molecular mechanisms. Methods: Plasmids expressing wild sequence (pGD) and mutation sequence (pGM) of hnRNP E2 decoy RNA were transfected into 32D-BCR/ABL cells with electroporation method. Stably transfected cells were selected with G418. The cell reproductive activity was detected by cell growth curve using trypan blue staining and colony formation test; the cell cycle was analyzed by flow cytometry ; the mRNA and protein expressions of downstream CCAAT/enhancer-biriding protein α(C/EBPα) and c-Myc were determined by RT-PCR and Western blot. Results:The stably expressed 32DP210-pGD cells and 32DP210-pGM cells were selected. The proliferation of 32DP210-pGD cells was inhibited compared with untreated 32D-BCR./ABL cells. The inhibitory rate was (69.48 ±5.21 ) %. The elony formation ability of 32DP210-pGD cells was weakened. The 32DP210-pGD cells were arrested at G0/G1 phase. The expression of C/EBPα mRNA of 32DP210-pGD cells remained unchanged, but the 42 ku-C/ EBPα protein expression was elevated by (43.83 ± 4.91 ) % ;mRNA and protein expression levels of c-Myc were decreased by (35.67 ± 6.64) % and (30.91 ±3.84) % , respectively. However, there was no significant difference between 32DP210-pGM cells and untreated 32D-BCR/ABL cells in the above mentioned parameters. Conclusion: hnRNP E2 decoy RNA inhibited the proliferation of 32D- BCR/ABL cell. The action mechanism of hnRNP E2 decoy RNA may be related with its effect of blocking the binding of hnRNP E2 with C/EBPα mRNA and subsequent elevation of 42 ku-C/EBPα and down-regulation of c-Myc gene expression.
出处 《肿瘤》 CAS CSCD 北大核心 2009年第6期518-522,共5页 Tumor
基金 国家自然科学基金资助项目(编号:30600748)
关键词 白血病 髓样 慢性 多聚嘧啶区结合蛋白质 CCAAT增强子结合蛋白α 细胞增殖 诱骗RNA Leukemia, myeloid, chronic Polypyrimidine tract-binding protein CCAAT-enhancer-binding protein α Cell proliferation Decoy RNA
  • 相关文献

参考文献7

  • 1CALABRETTA B, PERROTH D. The biology of CML blast crisis [J]. Blood,2004,103 ( 11 ) :4010-4022.
  • 2CHANG J S, SANTHANAM R,TROTTA R, et al. High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBP alpha-driven myeloid differention [ J ]. Blood, 2007,110 ( 3 ) : 994 -1003.
  • 3UTAMA F E, LEBARON M J, NEILSON L M,et al. Human prolaetin receptors are insensitive to mouse prolaetin implications for xenotransplant modeling of human breast cancer in mice[J]. J Endocrinol,2006,188 ( 3 ) :589-601.
  • 4JOHANSEN L M, LWAMA A, LODIE TA,et al. c-myc is a critical target for C/EBP alpha in granulopoiesis [ J ]. Mol Cell Biol,2001, 21 ( 11 ) :3789-3806.
  • 5王小中,冯文莉,曾建明,史梅,白卫君,赵世巧,曹唯希,涂植光,黄宗干.STAT 5诱杀寡脱氧核苷酸对K 562细胞裸鼠致瘤能力的影响[J].肿瘤,2007,27(12):935-938. 被引量:3
  • 6FUCHS O. Growth-inhibiting activity of transcription factor C/EBP alpha, its role in hacmatopoiesis and its tumour suppressor or oncogenic properties in leukaemias [J]. Folia Biol ( Praha ) , 2007, 53(3) :97-108.
  • 7KEESHAN K, HE Y, WOUTERS B J, et al. Tribbles homolog 2 inactivates C/EBP alpha and causes acute myelogenous leukemia [J]. Cancer Cell,2006,10 (5) :401-441.

二级参考文献7

  • 1王小中,冯文莉,史梅,曾建明,涂植光,黄宗干.诱骗寡核苷酸靶向阻断信号转导和转录活化蛋白5抑制K562细胞生长增殖[J].中华血液学杂志,2004,25(12):724-727. 被引量:4
  • 2MANN M J, DZAU V J. Therapeutic applications of transcription factor decoy oligonucleotides [J]. J Clin Invest, 2000, 106 ( 9 ) : 1071-1075.
  • 3SILLABER C, GESBERT F, FRANK DA, et al. STAT 5 activation contributes to growth and viability in Bcr/Abl-transformed cells[J]. Blood, 2000, 95(6):2118-2125.
  • 4EVAN GI, WYLLIE AH, GILBERT CS, et al. Induction of apoptosis in fibroblasts by c-myc protein[J]. Cell, 1992, 69( 1 ) : 119-128.
  • 5HANDA H, HEGDE UP, KOTELNIKOV VM, et al. Bcl-2 and c-myc expression, cell cycle kinetics and apoptosis during the progression of chronic myelogenous leukemia from diagnosis to blastic phase [ J ]. Leuk Res, 1997, (6) :479-489.
  • 6CHANG C Y, LEE J, KIM E Y, et al. Intratumoral delivery of IL- 18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model [ J ]. BMC Cancer, 2007, 7 : 87.
  • 7HERZOG R W, CAO O, HAGSTROM J N, et al. Gene therapy for treatment of inherited haematological disorders [ J ]. Expert Opin Biol Ther,2006,6(5) :509-522.

共引文献2

同被引文献19

  • 1陈新敏,冯文莉,赵世巧,曾建明,白卫君,王小中,黄宗干.HnRNP E2诱骗RNA对白血病K562细胞增殖的影响及其可能机制[J].癌症,2006,25(7):793-797. 被引量:4
  • 2ALFONSO Q C,JORGE C.Molecular biology of bcr-abl1-positive chronic myeloid leukemia[J].Blood,2009,113(8):1619-1630.
  • 3GIOVANNA F A,KAREN K,MICHELA Z,et al.Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBP[J].Blood,2006,108(4):1353-1362.
  • 4EIRING A M,HARB J G,NEVIANI P,et al.miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts[J].Cell,2010,140(5):652-665.
  • 5WAGNER K,ZHANG P,ROSENBAUER F,et al.Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy[J].Proc Natl Acad Sci U S A,2006,103(16):6338-6343.
  • 6SCHWIEGER M,LOHLER J,FISCHER M,et al.A dominant-negative mutant of C/EBP alpha,associated with acute myeloid leukemias,inhibits differentiation of myeloid and erythroid progenitors of man but not mouse[J].Blood,2004,103(7):2744-2752.
  • 7PERROTTI D,CESI V,TROTTA R,et al.BCR-ABL suppresses C/EBP alpha expression through inhibitory action of hnRNP E2[J].Nat Genet,2002,30(1):48-58.
  • 8MAKEYEV A V,EASTMOND D L,LIEBHABER S A.Targeting a KH-domain protein with RNA decoys[J].RNA,2002,8(9):1160-1173.
  • 9CHANG J S,SANTHANAM R,TROTTA R,et al.High levels of the bcr/abl oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differention[J].Blood,2007,110(3):994-1003.
  • 10KEESHAN K,HE Y,WOUTERS B J,et al.Tribbles homolog 2 inactivates C/EBP alpha and causes acute myelogenous leukemia[J].Cancer Cell,2006,10(5):401-411.

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部